News & Updates

Onasemnogene abeparvovec commonly linked to hepatotoxicity

27 Feb 2021

Hepatotoxicity is common after treatment with onasemnogene abeparvovec for spinal muscular atrophy, a recent study has found. Clinicians should anticipate and be ready to manage such adverse events, and be aware of any potential underlying conditions that could aggravate them.

Onasemnogene abeparvovec commonly linked to hepatotoxicity

27 Feb 2021

COVID-19 vaccines vs new variants: Are we protected?

27 Feb 2021 by

While more and more COVID-19 vaccines are getting rolled out globally, the world is also seeing new variants of SARS-CoV-2 emerging. How effective will the vaccines work against these new variants is largely unknown. Billions worldwide are watching closely and bracing themselves on how this might unfold.

COVID-19 vaccines vs new variants: Are we protected?

27 Feb 2021

Neck size useful in screening for metabolic syndrome

27 Feb 2021

Neck circumference aids in the detection of metabolic syndrome in adults, a study reports.

Neck size useful in screening for metabolic syndrome

27 Feb 2021

Immune checkpoint inhibitors deliver comparable effectiveness in advanced urothelial carcinoma

27 Feb 2021

The effectiveness of programmed cell death protein 1 or its ligand (L1) inhibitors is similar as regards time to initiation of third therapy or death and overall survival in patients with platinum refractory locally advanced/unresectable or metastatic urothelial carcinoma, a recent study has shown.

Immune checkpoint inhibitors deliver comparable effectiveness in advanced urothelial carcinoma

27 Feb 2021

Pancreatic enzymes supplementation leads to symptomatic recovery in sorafenib-treated HCC

27 Feb 2021

Supplementation with pancreatic enzymes results in symptomatic recovery in hepatocellular carcinoma (HCC), as shown in a study that validated the association between malabsorption (MA) and pancreatic insufficiency (PI) in 10 percent of sorafenib-treated patients.

Pancreatic enzymes supplementation leads to symptomatic recovery in sorafenib-treated HCC

27 Feb 2021

Risk for thrombotic events higher after respiratory infections needing hospitalization

27 Feb 2021

Being hospitalized for respiratory infections heightens the risk of myocardial infarction (MI) and venous thromboembolism (VTE), especially in the first 30 days after discharge, a recent study has found.

Risk for thrombotic events higher after respiratory infections needing hospitalization

27 Feb 2021

Metformin shields diabetics against tuberculosis

27 Feb 2021

Among patients with diabetes mellitus, the use of metformin may prove to be protective against tuberculosis, a recent study has found.

Metformin shields diabetics against tuberculosis

27 Feb 2021

Severe/critical COVID-19 may up perinatal risk

26 Feb 2021 by

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.

Severe/critical COVID-19 may up perinatal risk

26 Feb 2021

Decongestants do not aggravate stroke, MI risk

26 Feb 2021

The use of sympathomimetic decongestants does not seem to exacerbate the risk of stroke or myocardial infarction (MI), a recent study has found.

Decongestants do not aggravate stroke, MI risk

26 Feb 2021

Adjuvant S-1 + docetaxel yields survival benefit for stage III gastric cancer patients following resection

26 Feb 2021 by

A combination therapy of S-1 plus docetaxel in the adjuvant setting is not only superior to S-1 alone for recurrence-free survival (RFS) following D2 gastrectomy for stage III gastric cancer, it also confers overall survival (OS) benefit, according to the updated analysis of the JACCRO GC-07 trial presented at ASCO GICS 2021.

Adjuvant S-1 + docetaxel yields survival benefit for stage III gastric cancer patients following resection

26 Feb 2021

News & Updates

Filter by Specialty:

Specialty:

Onasemnogene abeparvovec commonly linked to hepatotoxicity

Onasemnogene abeparvovec commonly linked to hepatotoxicity

COVID-19 vaccines vs new variants: Are we protected?

COVID-19 vaccines vs new variants: Are we protected?

Neck size useful in screening for metabolic syndrome

Neck size useful in screening for metabolic syndrome

Immune checkpoint inhibitors deliver comparable effectiveness in advanced urothelial carcinoma

Immune checkpoint inhibitors deliver comparable effectiveness in advanced urothelial carcinoma

Pancreatic enzymes supplementation leads to symptomatic recovery in sorafenib-treated HCC

Pancreatic enzymes supplementation leads to symptomatic recovery in sorafenib-treated HCC

Risk for thrombotic events higher after respiratory infections needing hospitalization

Risk for thrombotic events higher after respiratory infections needing hospitalization

Metformin shields diabetics against tuberculosis

Metformin shields diabetics against tuberculosis

Severe/critical COVID-19 may up perinatal risk

Severe/critical COVID-19 may up perinatal risk

Decongestants do not aggravate stroke, MI risk

Decongestants do not aggravate stroke, MI risk

Adjuvant S-1 + docetaxel yields survival benefit for stage III gastric cancer patients following resection

Adjuvant S-1 + docetaxel yields survival benefit for stage III gastric cancer patients following resection